Get started
Amgen Inc.Amgen Inc.Amgen Inc.

Amgen Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

AMGN trade ideas

Repatha will bring major volume and take AMGN to new heights.Repatha (AMGN) and Praluent (Regeneron (REGN)/Sinofy (SNY)) are two PCSK9 inhibitors, a new class of drugs to treat hypercholesterolemia more effectively than previously possible. This will trigger a HCV-like battle between the two as both have high efficacy. Both have room to share the market, allowing both to make a significant amount of money on these blockbuster drugs. Unlike the HCV battle where GILD had more than a year of first-to-market status, Praluent will only have a month of such status assuming REGN/SNY can capitalize on that extra time to quickly bring it to the US market faster than AMGN. However, Repatha is expected to hit the EU market sooner, so it's a fair tradeoff as both will be able to get some good traction. Additional difference could be in the pricing strategy of Praluent being cheaper due to lower dosing, however Repatha has a slightly higher efficacy (61% vs 56% Praluent) and has noted a possible 50% reduction in cardiovascular disease. If AMGN is able to prove these claims with a large post-marketing study, Repatha will have a significant advantage due to the added secondary benefit and can easily command a higher price point. Important Repatha Dates: June 10 ADCOM Aug 27 PDUFA Important Praluent Dates: June 9 ADCOM July 24 PDUFA MM's taking this down to $157 is a bargain given the strength of the company's overall pipeline. At the very least, we should see some action heading into the ADCOM dates and both drugs are expected to easily get positive recommendations. EMA has already given positive recommendations for both drugs in May. EMA approval for Repatha is expected in September, shortly after the FDA approval.
NASDAQ:AMGNLong
by Elemental
4
Conditional Trade Bullish / Bearish Perspective(Summary).... On this chart I have highlighted the key areas of interest that I find important in navigating this stocks price action. I have listed the major support and resistance area. (Pattern Type) Inverse Head and Shoulders / Break Down (Target Price) 122 , 130 (Bull Perspective) In order for this trade to initiate price needs to break and hold 114 notice in the past when price tried to break this level it could not hold and resulted in a head fake so volume on a break and the ability to hold the break to the upside is crucial. (Bear Perspective) If price fails to break this resistance then a short trade may be in the works on signs of break down the first target for the short trade would be the bottom of the green channel then support floor 1. (Overall Market Influence) If the market receives a pull back in the coming days it may inhibit the bullish trade from taking place.
NASDAQ:AMGN
by StealthTrader
3